Recce Pharmaceuticals Ltd (ASX:RCE)

Recce Pharmaceuticals Statistics

Total Valuation

ASX:RCE has a market cap or net worth of AUD 121.46 million. The enterprise value is 121.54 million.

Market Cap	121.46M
Enterprise Value	121.54M

Important Dates

The next estimated earnings date is Wednesday, November 26, 2025.

Earnings Date	Nov 26, 2025
Ex-Dividend Date	n/a

Share Statistics

ASX:RCE has 289.18 million shares outstanding. The number of shares has increased by 33.81% in one year.

Current Share Class	289.18M
Shares Outstanding	289.18M
Shares Change (YoY)	+33.81%
Shares Change (QoQ)	+6.97%
Owned by Insiders (%)	38.94%
Owned by Institutions (%)	14.84%
Float	160.67M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	16.18
PB Ratio	-39.80
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-5.67
EV / Sales	16.19
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-5.94

Financial Position

The company has a current ratio of 1.86

Current Ratio	1.86
Quick Ratio	1.78
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-0.53
Interest Coverage	-16.87

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-135.80%
Return on Invested Capital (ROIC)	-293.44%
Return on Capital Employed (ROCE)	-324.67%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.80
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -20.75% in the last 52 weeks. The beta is 0.30, so ASX:RCE's price volatility has been lower than the market average.

Beta (5Y)	0.30
52-Week Price Change	-20.75%
50-Day Moving Average	0.42
200-Day Moving Average	0.37
Relative Strength Index (RSI)	52.50
Average Volume (20 Days)	179,334

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:RCE had revenue of AUD 7.51 million and -21.43 million in losses. Loss per share was -0.09.

Revenue	7.51M
Gross Profit	-2.94M
Operating Income	-20.41M
Pretax Income	-21.43M
Net Income	-21.43M
EBITDA	-20.33M
EBIT	-20.41M
Loss Per Share	-0.09

Balance Sheet

The company has 10.69 million in cash and 10.77 million in debt, giving a net cash position of -82,807 or -0.00 per share.

Cash & Cash Equivalents	10.69M
Total Debt	10.77M
Net Cash	-82,807
Net Cash Per Share	-0.00
Equity (Book Value)	-3.05M
Book Value Per Share	-0.01
Working Capital	5.26M

Cash Flow

In the last 12 months, operating cash flow was -20.44 million and capital expenditures -26,347, giving a free cash flow of -20.47 million.

Operating Cash Flow	-20.44M
Capital Expenditures	-26,347
Free Cash Flow	-20.47M
FCF Per Share	-0.07

Margins

Gross margin is -39.12%, with operating and profit margins of -271.76% and -285.37%.

Gross Margin	-39.12%
Operating Margin	-271.76%
Pretax Margin	-285.37%
Profit Margin	-285.37%
EBITDA Margin	-270.81%
EBIT Margin	-271.76%
FCF Margin	n/a

Dividends & Yields

ASX:RCE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-33.81%
Shareholder Yield	-33.81%
Earnings Yield	-17.64%
FCF Yield	-16.85%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ASX:RCE has an Altman Z-Score of -10.7 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-10.7
Piotroski F-Score	2